300529.SZ SHZ
Jafron Biomedical Co.,Ltd.
1W: +0.0%
1M: -3.2%
3M: -5.8%
YTD: -24.9%
1Y: -34.5%
3Y: -29.1%
5Y: -79.9%
¥15.27 ($2.28)
+0.34 (+2.28%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥12.2B ($1.8B)
52W Range14.73-22.29
Volume4,690,512
Avg Volume7,047,692
Beta0.31
Dividend¥0.52
Analyst Ratings
No analyst coverage
Company Info
CEOFan Dong
Employees2,200
SectorHealthcare
IndustryMedical - Specialties
IPO Date2016-08-02
Websitejafroninternational.com
No. 98 Technology Six Road
Zhuhai, GD 519085
CN
Zhuhai, GD 519085
CN
86 75 6361 9988
About Jafron Biomedical Co.,Ltd.
Jafron Biomedical Co.,Ltd. engages in the research and development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.
Latest News
No recent news
Recent Insider Trades
No insider trades found